Healthcare - Biotechnology - NASDAQ - CA
$ 4.25
-3.19 %
$ 146 M
Market Cap
-3.79
P/E
Price Target
Average
158.82%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
37.80%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Achieve Life Sciences, Inc.
Wall Street analysts predict an average 1-year price target for ACHV of $11 , with forecasts ranging from a low of $11 to a high of $11 .
ACHV Lowest Price Target
Wall Street Target
11 USD
158.82%
ACHV Average Price Target
Wall Street Target
11 USD
158.82%
ACHV Highest Price Target
Wall Street Target
11 USD
158.82%
REVENUE FORECAST
Revenue Forecast Chart ACHV
EBIT FORECAST
EBIT Forecast Chart ACHV
NET INCOME FORECAST
Net Income Chart ACHV